New ALS diagnostic blood test boasts 97% accuracy

ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is relatively rare, with an incidence rate of 1.6 per 100,000 adults, resulting in about 30,000 cases in the United States at any one time.

Unfortunately, ALS is difficult to diagnose in the early stages. Some patients take over a year from the first onset of symptoms for ALS to receive an accurate diagnosis, with up to 68% of ALS patients initially misdiagnosed. Patients are often shuttled between medical specialists before finally being evaluated by a neurologist with ALS experience.

A new rapid blood test for ALS has been developed by scientists at the not-for-profit Brain Chemistry Labs in Jackson Hole, Wyoming. Based on analysis of 788 patient blood samples, including 393 ALS patients and 395 age- and gender-matched healthy controls, this new test can identify a person who has ALS with 97% accuracy from a single blood draw. In addition, this new test can also rule out patients who do not have ALS.

Sign up for Blog Updates